Roger Hajjar, MD, on Gene Therapy as a Novel Precision Medicine Modality in Cardiology
The director of the Mass General Brigham Gene and Cell Therapy Institute shared his main message for cardiologists at the American Heart Association’s Scientific Sessions 2023.
Roger Hajjar, MD, on Bringing Gene Therapy to Cardiology
The director of the Mass General Brigham Gene and Cell Therapy Institute discussed the history and future of gene therapy in cardiology at the American Heart Association’s Scientific Sessions 2023.